Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in the Nordic Countries, Denmark, Finland, Iceland, Norway and Sweden, or involving organisations from these countries.

Total search results: 955 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
NMD Pharma–Novo Group: investment, 201606 seed funding round totalling €3m from Lundbeckfonden Emerge + Novo Seeds + Capnova 2016-06-13
NMD Pharma–SEVERAL: investment, 201606 seed funding round €3m from Lundbeckfonden Emerge + Novo Seeds + Capnova 2016-06-13
United States (govt)–Bavarian Nordic: Imvamune®, 201605– contract $100m bulk supply convertable into freeze-dried version from BARDA 2016-05-19
AstraZeneca–Univ Helsinki: genomics, 201604– collab FIMM is one of three initial partners in AZ’s new integrated strategic genomics initiative 2016-04-22
Enterome–BPCE: investment, 201604 financing round Series C totalling €14.5m incl co-lead + existing investor Seventure Partners 2016-04-20
Enterome–Lundbeck: investment, 201604 financing round Series C totalling €14.5m incl co-lead + existing investor Lundbeckfond Ventures 2016-04-20
Enterome–Nestlé: investment, 201604 financing round Series C totalling €14.5m incl new + co-investor Nestlé Health Science 2016-04-20
Enterome–SEVERAL: investment, 201604 financing round Series C €14.5m led by Seventure Partners + Lundbeckfond Ventures plus Nestlé Health et al 2016-04-20
BioInvent–Omega Advisors: investment, 201603–201604 private placement SEK43m to Omega Funds 2016-04-15
Bavarian Nordic–SEVERAL: investment, 201604 private placement DKK665m ($102m) w 2.77m new shares at DKK240/share 2016-04-13
Symphogen–Consilium: public relations, 201604 service existent by CSC 2016-04-12
Agilent–Applied Spectral Imaging: FISH technology, 201604– collab co-marketing of GenASIs imaging platform w Agilent FISH products + solutions 2016-04-07
BioSilta–Univ Oulu: protein expression technology, 201604– license ww excl to CyDisCo technology to be combined with EnPresso culture systems 2016-04-06
Qiagen–BioTeam: bioinformatics, 201604 collab existent to create high-performance appliance with CLC Genomics Server + BioTeam Appliance platform 2016-04-05
Qiagen–Intel: bioinformatics, 201604 collab existent to develop reference architecture for high-volume whole genome data analysis 2016-04-05
Anergis–SEVERAL: investment, 201604 financing round extension CHF5m to conduct phase 2b study with AllerT from existing investors 2016-04-04
Entasis Therapeutics–Novo Group: investment, 201604 financing round Series B totalling $50m incl co-investor Novo A/S 2016-04-04
Entasis Therapeutics–SEVERAL: investment, 201604 financing round Series B $50m led by Clarus plus Frazier Healthcare + Novo + Eventide Funds 2016-04-04
BioSilta–Image Box: public relations, 201604– supply service BioSilta Ldt new client of Image Box PR 2016-04-01
Exiqon–Qiagen: investment, 201603–201606 conditional voluntary takeover offer DKK683m ($100m) 2016-03-29
Bayer–Holta Invest: investment, 201603 existent Bayer listed as portfolio company of Holta Life Sciences 2016-03-28
Biolink (NO)–Holta Invest: investment, 201603 existent Biolink Group listed as portfolio company of Holta Life Sciences 2016-03-28
Cempra–Holta Invest: investment, 201603 existent Cempra Inc listed as portfolio company of Holta Life Sciences 2016-03-28
Cortendo–Holta Invest: investment, 201603 existent Cortendo AB listed as portfolio company of Holta Life Sciences 2016-03-28
Mylan–Holta Invest: investment, 201603 existent Mylan listed as portfolio company of Holta Life Sciences 2016-03-28
OncoMed Pharmaceuticals–Holta Invest: investment, 201603 existent OncoMed listed as portfolio company of Holta Life Sciences 2016-03-28
PreTect–Holta Invest: investment, 201603 existent PreTect listed as portfolio company of Holta Life Sciences 2016-03-28
Roche–Holta Invest: investment, 201603 existent Roche listed as portfolio company of Holta Life Sciences 2016-03-28
BioInvent–SEVERAL: investment, 201603–201604 capital increase SEK190.6m 2016-03-23
Onxeo–Alize RP: public relations, 201603 service existent by Alize RP 2016-03-21
BerGenBio–SEVERAL: investment, 201603 financing round NOK212m=$25m private placing to existing investors 2016-03-18
Protein Technologies (US)–Gyros: investment, 201603 merger of Gyros AB + Protein Technologies Inc into Gyros Protein Technologies AB 2016-03-16
AstraZeneca–Lipigon Pharmaceuticals: cardiovascular drugs, 201603– collab up to $110m milestones drug discovery LPL-stabilizing small-molecule drugs 2016-03-14
Outpost Medicine–SEVERAL: investment, 201603 financing round Series A $41m led by Frazier Healthcare + incl Novo A/S et al 2016-03-14
Aprea–MC Services: public relations, 201602 service existent for Aprea AB 2016-03-09
Aprea–SEVERAL: investment, 201603 financing round Series B €46m co-led by Versant Ventures + 5AM Ventures incl HealthCap et al 2016-03-09
Biolink (NO)–Evonik: investment, 201603 acquisition €na of MedPalett AS by Evonik from Biolink Group 2016-03-03
DNA Therapeutics–Onxeo: investment, 201602–201603 acquisition upfront €1.7m in shares + €1m milestones cash or shares + royalties €25m/indication 2016-02-29
Blue Scientific–Accurion: laboratory instruments, 201602– distribution Nanofilm Technology + Halcyonics products in UK + Nordics by Blue Scientific 2016-02-25
Redwood Pharma–SEVERAL: investment, 201602 private placement SEK6.6m 2016-02-23
Univ Copenhagen–Waters: mass spectrometer, 201602 supply existent Xevo QTOF mass spectrometers combined with Acquity UPLC 2016-02-16
Waters–Univ Copenhagen: mass spectrometry, 201602– collab Forensic Chemistry Lab joins Waters Centers of Innovation Program 2016-02-16
Meda–Mylan: investment, 201602–201608 recommended public acquisition offer SEK83.6b ($9.9b) in cash + shares with value of SEK165/share 2016-02-10
Qiagen–CosmosID: bioinformatics, 201602– collab integration of CosmosID metagenomics analysis platform in CLC Genomics Workbench 2016-02-02
Nordic Nanovector–Norway (govt): grant, 201602– BIA grant up to NOK15m over 3y from Research Council of Norway to develop ARCs 2016-02-01
Vaccibody–Norway (govt): grant, 201602– BIA grant up to NOK20m ($2.3m) over 4y from Research Council of Norway to develop cancer vaccines 2016-02-01
Vanadis Diagnostics–PerkinElmer: investment, 201601 acquisition of Vanadis Diagnostics by PE 2016-01-26
Synoste–Evonik: investment, 201601 financing round Series A single-digit €n from Evonik + HTGF + Finnvera + Lifeline Ventures + business angels 2016-01-21
Synoste–High-Tech Gründerfonds: investment, 201601 financing round Series A single-digit €m from Evonik + HTGF + Finnvera + Lifeline Ventures + angels 2016-01-21
Synoste–SEVERAL: investment, 201601 financing round Series A single-digit €n from Evonik + HTGF + Finnvera + Lifeline Ventures + business angels 2016-01-21
Biotie–Acorda: investment, 201601–201609 recommended cash tender offer €321m by Acorda 2016-01-19
Nordic Nanovector–Huntsworth: public relations, 201601 service existent media relations by Citigate Dewe Rogerson 2016-01-08
IO Biotech–SEVERAL: investment, 201601 financing round Series A €11m from Lundbeckfonden + Novo A/S 2016-01-05
JnJ–Bavarian Nordic: vaccine technology, 201512– license + collab $9m upfront + $171m milestones + royalties using MVA-BN with AdVac for HPV vaccine 2015-12-18
Nexstim–SEVERAL: investment, 201512 private placement €5.28m with 880k shares for €6/share 2015-12-16
Lytix Biopharma–SEVERAL: investment, 201512 capital increase NOK80m w 224.2k new shares at NOK350/share to existent + new shareholders 2015-12-15
UBM–Cision: investment, 201512–201606 acquisition $841m with $810m in cash + $31m preferred equity of PR Newswire by Cision from UBM plc 2015-12-15
Inthera Bioscience–SEVERAL: investment, 201512 seed financing round €3.4m led by MS Ventures incl Aglaia + Novo Seeds + EVA Basel 2015-12-14
AstraZeneca–KTH (SE): proteomics, 201512– collab research w new Wallenberg Centre for Protein Research based on secretome analysis 2015-12-11
Sofinnova–SEVERAL: investment, 201512 closing €300m of Sofinnova Capital VIII fund 2015-12-08
Novo Group–Eleven Biotherapeutics: drug delivery technology, 201512 acquisition €na of Supermin albumin variant assets from Eleven Bio by Albumedix 2015-12-04
Athera Biotechnologies–Karolinska Development: investment, 201512 DIVESTMENT of entire shareholding in Athera for an earn-out 2015-12-03
Karolinska Development–Huntsworth: public relations, 201512 service existent media relations by Citigate Dewe Rogerson 2015-12-03
Alvogen–Insilico Biotechnology: bioinformatics, 201511– collab Alvotech using Insilico simulation s/w to develop biosimilars using mammalian cells 2015-11-27
AstraZeneca–Pelago Bioscience: drug discovery technology, 201511–201710 license + collab developm CETSA to analyse drug-target interactions 2015-11-27
Novo Group–Ablynx: Nanobodies, 201511– collab + license ww excl discovery + developm of Nanobodies Novo Nordisk 2015-11-25
Nuevolution–SEVERAL: investment, 201511–201512 IPO SEK250m at First North Premier Stockholm 2015-11-20
Immunovia–SEVERAL: investment, 201511–201512 IPO SEK60m w 3.245m new shares at Nasdaq First North 2015-11-16
Astellas–Leo Pharma: investment, 201511 acquisition €675m asset purchase of global dermatology portfolio of Astellas by Leo Pharma 2015-11-11
OssDsign–SEVERAL: investment, 201511 financing round SEK93m (€9.6m) co-lead by new investors SEB Venture Capital + Fouriertransform 2015-11-04
Apta Biosciences–EU (govt): grant, 201511– Horizon 2020 grant €940k as part of MARA project to develop new antiinfectives 2015-11-01
BFCC project–EU (govt): grant, 201511– grant €3.6m for Baltic Fracture Competence Centre from Interreg Baltic Sea Region Programme 2015-11-01
BFCC project–Hamburg (govt): healthcare, 201511– Life Science Nord Management GmbH is lead partner in Baltic Fracture Competence Centre 2015-11-01
MARA project–EU (govt): grant, 201511– Horizon 2020 grant €3m to develop new anti-infectives 2015-11-01
Sigma-Aldrich–Olink: research reagents, 201510 acquisition of Duolink product portfolio by Sigma-Aldrich 2015-10-29
BioLamina–Cevec: rec protein production technology, 201510– license €na to CAP Go technology for laminins for ex vivo cell culture therapies 2015-10-28
Cevec–iBET (PT): rec protein production, 201510 collab existent GenIbet is joint venture partner of Cevec 2015-10-28
Alzinova–SEVERAL: investment, 201510 IPO SEK16.7m (€1.78m) net SEK15.4m + 2 warrants for each 3 shares at AktieTorget 2015-10-27
Symphogen–SEVERAL: credit, 201510 convertible debt facility €67.5m secured by existing investors Novo A/S + PKA 2015-10-22
JnJ–Nuevolution: drug discovery services, 201510– collab using Chemetics technology to discover compounds against Janssen Biotech targets 2015-10-19
Encycle Therapeutics–BDC Capital: investment, 201509 financing round totalling C$2.85m incl co-investor BDC Capital 2015-09-30
Encycle Therapeutics–Canada (govt): investment, 201509 financing round totalling C$2.85m incl co-investor Accel-Rx Health Sciences Accelerator 2015-09-30
Encycle Therapeutics–Ontario (govt): investment, 201509 financing round totalling C$2.85m incl co-investor MaRS Investment Accelerator Fund 2015-09-30
Encycle Therapeutics–SEVERAL: investment, 201509 financing round C$2.85m led by Takeda Ventures 2015-09-30
Encycle Therapeutics–Takeda: investment, 201509 financing round totalling C$2.85m incl lead investor Takeda Ventures 2015-09-30
Cobra Biologics–Univ Manchester: protein production technology, 201509– collab 2 years to improve industrial scale-up of therap protein production 2015-09-24
JnJ–Nextera: phage display technology, 201509– collab research using Nextera technology platform in area of RA JnJ Innovation Centre London 2015-09-21
Nextera–Birk Venture: investment, 201509 existent by Birk Venture 2015-09-21
Nextera–Univ Oslo: investment, 201509 existent by Norwegian Radium Hospital Research Foundation 2015-09-21
XSpray Microparticles–Karolinska Development: investment, 201509 DIVESTMENT by Karolinska Development to Östersjöstiftelsen & Recipharm et al 2015-09-20
XSpray Microparticles–SEVERAL: investment, 201509 investment SEK18m by Östersjöstiftelsen & Recipharm Venture Fund while taking over Xspray 2015-09-20
Mind the Byte–SEVERAL: investment, 201509–201510 financing round €234k via crowdfunding platform Crowdcube 2015-09-17
Seahorse Bioscience–Life Sciences Partners: investment, 201509 DIVESTMENT EXIT sale of Seahorse Bioscience to Agilent 2015-09-14
Seahorse Bioscience–Agilent: investment, 201509–201511 acquisition $235m in cash by Agilent 2015-09-09
Sanifit–Lundbeck: investment, 201509 financing round Series C totalling €36.6m incl new + co-investor Lundbeckfond Ventures 2015-09-08
Sanifit–SEVERAL: investment, 201509 financing round Series C €36.6m led by Ysios Capital incl Lundbeckfound + Forbion + Gilde + EdRIP + la Caixa 2015-09-08
Faron Pharmaceuticals–SEVERAL: investment, 201509–201511 IPO £10m with 3.85m new ordinary shares at 260p/share at AIM 2015-09-07
TFS Trial Form Support–Ratos: investment, 201509– acquisition 60% share in TFS for up to €27m by Ratos AB 2015-09-07
Boehringer–Vectron Biosolutions: gene expression technology, 201509– license non-excl to Vectron technology for use w BI e. coli production system 2015-09-01
Genmab–Fidelity: investment, 201509 FMR LLC increased indirect ownership to 5.9m shares = 10% of share capital + voting rights of Genmab 2015-09-01
next pagenext page 1 2 3 4 5 6 7 8 9 10  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

» top